Matches in Wikidata for { <http://www.wikidata.org/entity/Q91576474> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q91576474 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q91576474 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91576474 description "scientific article published on 01 July 2018" @default.
- Q91576474 description "wetenschappelijk artikel" @default.
- Q91576474 description "наукова стаття, опублікована в липні 2018" @default.
- Q91576474 name "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 name "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 type Item @default.
- Q91576474 label "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 label "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 prefLabel "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 prefLabel "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 P1433 Q91576474-9E2D6716-E5DE-4214-9F3C-7C45B1AD9D8A @default.
- Q91576474 P1476 Q91576474-F23A9666-B9E5-45C1-9282-12C7830DE902 @default.
- Q91576474 P2093 Q91576474-1BB10A70-5DCC-4114-A452-63242FA20EFA @default.
- Q91576474 P2093 Q91576474-2AEF2063-2ABD-4FDA-BF0E-E6E8B643504F @default.
- Q91576474 P2093 Q91576474-30F16F30-F850-424B-AF96-486B730EBB94 @default.
- Q91576474 P2093 Q91576474-912C2F3F-5E77-4BBE-BFF9-0E87BC5D2147 @default.
- Q91576474 P2093 Q91576474-A2592640-600B-416F-96CC-B82FF86ABF51 @default.
- Q91576474 P304 Q91576474-DF9E3CF6-F08A-4556-A5FE-E4667725452C @default.
- Q91576474 P31 Q91576474-53B5F3CD-F797-4D3B-B284-97EDBD17783C @default.
- Q91576474 P356 Q91576474-AB1104A6-68E3-4C08-8441-1491E647386C @default.
- Q91576474 P433 Q91576474-F646F3DF-8209-4927-B33A-4E82C180F1B4 @default.
- Q91576474 P478 Q91576474-3F00CB1E-67BD-4639-8714-E6D1A75A70EA @default.
- Q91576474 P50 Q91576474-D10BAC11-A3D5-4A82-BD46-6E2A94325840 @default.
- Q91576474 P577 Q91576474-7EBB5144-55BA-431C-A058-0C2FD6F5316A @default.
- Q91576474 P698 Q91576474-13F30071-9603-4609-B48F-A354740A3DB4 @default.
- Q91576474 P932 Q91576474-7D744CFC-AB6B-4C32-9132-F9CE387DD770 @default.
- Q91576474 P356 JOM.2018.0461 @default.
- Q91576474 P698 30234926 @default.
- Q91576474 P1433 Q15762496 @default.
- Q91576474 P1476 "Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified" @default.
- Q91576474 P2093 "Benjamin J Morasco" @default.
- Q91576474 P2093 "Michael I Demidenko" @default.
- Q91576474 P2093 "Steven K Dobscha" @default.
- Q91576474 P2093 "Thomas H A Meath" @default.
- Q91576474 P2093 "Travis I Lovejoy" @default.
- Q91576474 P304 "295-303" @default.
- Q91576474 P31 Q13442814 @default.
- Q91576474 P356 "10.5055/JOM.2018.0461" @default.
- Q91576474 P433 "4" @default.
- Q91576474 P478 "14" @default.
- Q91576474 P50 Q49364979 @default.
- Q91576474 P577 "2018-07-01T00:00:00Z" @default.
- Q91576474 P698 "30234926" @default.
- Q91576474 P932 "8011997" @default.